Biogen Paying Billion Company Signals BIIB Turnaround
Biogen’s $1 billion move on a mystery company has investors buzzing. This article breaks down why the deal could be a...
Curbing bad spending requires actionable steps like setting limits, automating savings, and choosing mindful alternatives to impulsive buys.
13,525 articlesBiogen’s $1 billion move on a mystery company has investors buzzing. This article breaks down why the deal could be a...
As AMD gathers AI momentum and potential customer wins, july could month stock scenarios could tilt in favor of patie...
Morgan Stanley argues that a selective rotation is underway as the chip pullback ushering bumpy market reshapes leade...
As SpaceX prepares to debut on the public market, analysts clash over whether the company is fairly valued amid volat...
SK Hynix's $29 billion ADR listing becomes a live test of whether the memory cycle can endure. Markets will parse dem...
Palantir surging in July shines a contrast with Google’s cloud-driven growth. Both giants report strong quarters, but...
A sharp escalation in the Middle East sees Iran strike U.S. military bases, triggering a broad market selloff and a s...
A $700,000 nest egg could buy a quieter coastline, but only if the home is paid for and island expenses are counted h...
Cybersecurity stocks are commanding attention as threats rise and tech spending grows. This July guide breaks down ho...
Starbucks is building in-house AI tools to reduce its reliance on Microsoft and IBM software, aiming to cut costs and...
Super Micro Computer stock tumbled 29% in a month as Dell and HPE rally on AI growth. Analysts weigh whether investor...
SK Hynix rode a Nasdaq debut to a turning point in AI hardware, with a $26.5 billion raise and 58% HBM market share. ...